Evidence map›Paper›PMID 38543061›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Head-to-Head Comparison of SSTR Antagonist [

Rahul Viswanathan, Sanjana Ballal, Madhav P Yadav, Frank Roesch, Parvind Sheokand, Swayamjeet Satapathy, Madhavi Tripathi, Shipra Agarwal, Euy Sung Moon, Chandrasekhar Bal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Research process of PET tracers for neuroendocrine tumors diagnosis.American journal of nuclear medicine and molecular imaging · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Rahul ViswanathanDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0009-0005-4984-169X
Sanjana BallalDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Madhav P YadavDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Frank RoeschDepartment of Chemistry-TRIGA Site, Johannes Gutenberg University, 55128 Mainz, Germany.
Parvind SheokandDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0003-4589-2623
Swayamjeet SatapathyDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Madhavi TripathiDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
Shipra AgarwalDepartment of Pathology, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0001-7037-4444
Euy Sung MoonDepartment of Chemistry-TRIGA Site, Johannes Gutenberg University, 55128 Mainz, Germany.
Chandrasekhar BalDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
All India Institute of Medical Sciences · INJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumors (NETs) are slow-growing tumors that express high levels of somatostatin receptors (SSTRs). Recent studies have shown the superiority of radiolabeled SSTR antagonists in theranostics compared to agonists. In this prospective study, we compared the diagnostic efficacy between [

Indexed as

[68Ga]Ga-DATA5m-LM4[68Ga]Ga-DOTANOCNETsneuroendocrine tumorsPET/CTSSTR antagonist

Identifiers

PMID38543061
PMCPMC10974918
OpenAlexW4392051786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.